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1 General introduction 
The term vitamin E refers to a group of naturally occurring compounds that include 
tocopherols and tocotrienols [1]. α- and γ-tocopherol are the main forms of vitamin 
E found in human diet [2]. α-tocopherol represents over 90% of the total vitamin E 
in plasma and is, thus, the most abundant and biologically active form of vitamin E 
[3, 4]. The concentration of α-tocopherol in plasma is, therefore, the most commonly 
used biomarker of vitamin E status in humans [3, 4]. Vitamin E is known to have 
important anti-oxidative and potentially anti-inflammatory functions that may reduce 
the risk for many chronic disease conditions, including atherosclerosis, diabetes, 
kidney disease, and cancer [1, 5, 6]. 
 
1.1  Properties and relevance of vitamin E  
1.1.1  Chemistry and function  
The vitamin E family encompasses eight lipophilic molecules, including four 
tocopherols (α, β, γ, δ) and four tocotrienols (α, β, γ, δ) [1]. All vitamin E forms 
possess a similar chemical structure consisting of a chromanol ring with a side chain 
with 16 carbon atoms (C16). Specifically, α-tocopherol has three methyl (CH3) 
groups at the 5-, 7-, and 8-positions of the chromanol ring, whereas γ-tocopherol is 
dimethylated at the 7-, and 8-positions of the chromanol ring [1, 6].  
The anti-oxidative properties of vitamin E are well established [1]. Specifically, 
vitamin E is able to react with free radicals in cell membranes, thereby preventing 
polyunsaturated fatty acids from being damaged by lipid peroxidation [1, 7, 8]. 
Compared to α-tocopherol, γ-tocopherol is slightly less efficient as a scavenger of 
free radicals, but it is superior to trap reactive nitrogen oxide species and also 
possesses anti-inflammatory activities [6, 9]. Furthermore, vitamin E also exhibits 
non-anti-oxidant activities, including modulation of gene expression and inhibition of 
cell proliferation [2].  
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1.1.2  Physiology of vitamin E 
This paragraph summarizes intestinal absorption, vascular transport, hepatic 
metabolism, and the excretion of vitamin E [10]. 
After the intake of dietary vitamin E, various tocopherol forms are absorbed in the 
small intestine. In the intestinal lumen, dietary vitamin E is solubilized into mixed 
micells by bile salts and other lipids. Absorption of dietary vitamin E is highly 
variable, ranging from 20% to 80% [10, 11]. Unabsorbed vitamin E is excreted in 
faeces, while absorbed and metabolized vitamin E is excreted via the bile or urine 
(as α- and γ-carboxyethyl hydroxychroman (CEHC)) [11, 12].  
For the absorption, vitamin E requires the presence of fat and is involved in 
biochemical and molecular processes which are related to lipid and lipoprotein 
metabolism [13]. After the intestinal absorption through a mechanism that is not 
entirely clarified, vitamin E is packed into chylomicrons and enters the systemic 
circulation via the lymphatic system [10, 14].  
After entering the systemic circulation, vitamin E has several possible metabolic 
pathways: 
A small amount of vitamin E is transferred from chylomicrons to high density 
lipoproteins (HDL), from where vitamin E can be distributed to circulating 
lipoproteins [14].  
Another pathway comprises the degradation of chylomicrons by the action of 
lipoprotein lipase, whereas a small proportion of vitamin E is transported to 
extrahepatic tissues such as lungs, kidney, adipose tissue, and skeletal muscle [15].  
The major pathway includes the transport of vitamin E via chylomicron remnants to 
the liver [10, 14]. To this point, there is no discrimination between different vitamin 
E forms [16]. In the liver, the hepatic α-tocopherol transfer protein (TTP) sorts out α-
tocopherol for incorporating into very low density lipoproteins (VLDL) [10]. Of note, 
a-TTP preferentially transfers α-tocopherol due to its specific biochemical structure 
[12, 17]. The mechanism by which VLDLs are enriched with α-tocopherol is poorly 
understood [2, 12]. In the blood circulation, α-tocopherol is transported back to the 
liver and to extrahepatic tissues by circulating lipoproteins, including, e.g., low 
density lipoproteins (LDL). [10, 16]. α-TTP is considered to be a major regulator for 
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maintaining normal α-tocopherol concentrations in plasma [18]. Indeed, the relative 
affinity of α-TTP to other tocopherols is substantially lower (β-tocopherol=38%, γ-
tocopherol=9%, and δ-tocopherol=2%) than to α-tocopherol (100%) [19].  
 
1.1.3  Sources of vitamin E and recommendations for dietary vitamin E intake 
and plasma vitamin E levels 
Sources of vitamin E 
Vitamin E is an essential nutrient for the human body and, thus, it must be provided 
by foods [20]. Almost 90% of the German population consume vitamin E in the form 
of α- and γ-tocopherol [21]. Foods containing high concentrations of both, α- and γ- 
tocopherol, are mainly vegetable oils [1]. Besides, the most commonly consumed 
oil in Germany is rapeseed oil [22], which is rich in α- and γ-tocopherol and is, 
therefore, the most important source of vitamin E [23]. In the European diet, α-
tocopherol is the predominant vitamin E form, while γ-tocopherol is the major dietary 
form of vitamin E in the United States (US) [1, 9]. 
 
Recommendations of vitamin E - dietary intake and plasma levels 
The recommended daily intake for vitamin E is based on the reported effects of 
vitamin E on the prevention of lipid peroxidation [10]. The German Society of 
Nutrition (DGE, Deutsche Gesellschaft für Ernährung) recommends a vitamin E (α-
tocopherol equivalent) intake of 12 mg/day for women and 13-15 mg/day for men 
[24]. For infants, children, and the elderly, a different daily vitamin E intake is 
recommended. So far, no adverse effects associated with vitamin E consumption 
from naturally occurring vitamin E in foods have been described [14]. With respect 
to vitamin E recommendations for the European population, the European Food 
Safety Authority Panel on Dietetic Products, Nutrition and Allergies set an Adequate 
Intake of 11 mg/day for women and 13 mg/day for men for α-tocopherol [25]. 
With respect to circulating vitamin E levels, the DGE recommends plasma vitamin 
E levels between 12 and 46 μmol/L [24]. Plasma concentrations <12 μmol/L may 
result in functional deficiencies in the human body [26], while plasma α-tocopherol 
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concentrations of about 30 µmol/L have been recommended to prevent nutrition-
related diseases and to reduce the risk for common disease conditions, including 
cardiovascular diseases and different types of cancer [8]. In contrast to α-
tocopherol, γ-tocopherol has received less scientific attention, so far, because its 
bioavailability and bioactivity are lower than for α-tocopherol [6]. Furthermore, γ-
tocopherol is not included in the current dietary intake recommendations [24]. 
However, increasing evidence suggests that γ-tocopherol may have beneficial 
biological properties such as anti-inflammatory activities [27]. 
 
1.2  Assessment of vitamin E in epidemiological studies  
In epidemiological studies, dietary intake of vitamin E can be estimated using 
established questionnaires [28]. Furthermore, vitamin E concentrations can be 
measured in blood using high performance liquid chromatography (HPLC) [29].  
 
1.2.1  Questionnaire-based assessment of vitamin E intake 
Established instruments to retrospectively assess self-reported dietary vitamin E 
intake include, for example, the 24-hour dietary recall and the food frequency 
questionnaire (FFQ) [28].  
The FFQ inquiries the dietary intake of the past 12 months and is, thus, an 
instrument to assess rather long-term eating habits, whereas the 24-hour dietary 
recall focusses on short-term intake [28, 30]. 
Specifically, the FFQ records the frequency, and in some cases portion size 
information, by which an individual consumes foods (food groups, single foods) and 
beverages [28]. For the papers included in the present thesis, the dietary vitamin E 
intake from the consumed food recorded in the FFQ was determined from the 
Department of Epidemiology of the German Institute of Human Nutrition Potsdam 
Rehbrücke by using the German Food Code and Nutrient Data Base (version II.3) 
[31]. In our Northern German sample, we used a FFQ that was specifically adjusted 
for the German population [32]. The FFQ tends to underestimate the dietary intake 
CHAPTER 1  GENERAL INTRODUCTION 
5 
 
of vitamin E because the FFQ does not capture foods (e.g., olives), which are 
contributing to vitamin E intake [33, 34].  
In a 24-hour dietary recall, participants are asked to describe in detail and in an 
open-ended manner the foods and beverages consumed in the last 24 hours [35]. 
Detailed data regarding the time of the consumed food, food preparation methods, 
recipe ingredients, and the brand name of products are necessary [28]. To estimate 
the average dietary intake of given individuals, several 24-hour dietary recalls are 
needed [28].  
 
1.2.2  Measuring vitamin E levels in plasma  
Several methods have been used for the assessment of the vitamin E status, 
including measurements of α-tocopherol concentrations in plasma, blood 
components (e.g., red blood cells, platelets), and body stores (e.g., adipose tissue) 
[36]. In fact, plasma α- and γ-tocopherol levels are the most commonly used 
biomarker of the current vitamin E status in epidemiological studies and are 
technically simple to measure [37]. Circulating vitamin E levels either in plasma or 
in serum can be determined by HPLC, which is the method of choice [38]. This 
method is able to measure simultaneously various tocopherols, particularly α- and 
γ-tocopherol [29, 39]. 
With regard to other measurements of the vitamin E status, for example, the 
measurement of α-tocopherol concentrations in red blood cells and platelets can 
provide a valid measurement of the vitamin E status [38]. However, both approaches 
are technically difficult and are therefore not commonly used to determine the 
vitamin E status [38]. Furthermore, the α-tocopherol concentration in red blood cells 
is only a fraction (about 20%) of the α-tocopherol concentration in plasma [36]. 
Moreover, vitamin E can also be determined in adipose tissue. Vitamin E 
concentrations in adipose tissue reflect more the long-term vitamin E status than the 
current status [40]. However, adipose tissue biopsies are invasive and, thus, not 
applicable in large scale epidemiological studies [26].  
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1.3  Correlates of circulating vitamin E levels: Dietary intake 
Dietary intake is an important determinant of circulating vitamin E concentrations 
and, as mentioned above, vegetable oils are important sources of vitamin E [1]. 
However, several prior studies reported relatively poor or no correlations between 
dietary vitamin E intake (assessed, e.g., by FFQ) and circulating vitamin E 
concentrations [41-43]. 
In order to look beyond the health-related effects of individual nutrients or foods, 
dietary pattern analysis has emerged as a more comprehensive assessment of diet, 
which reflects more complex combinations of nutrients that may interact in their 
biological effects [44]. Thus far, only two prior US studies have related circulating 
plasma vitamin E levels to a posteriori derived dietary patterns [42, 45]. Gao et al. 
observed [42] that participants (n=602) in a “sweet” dietary pattern had the lowest 
α-tocopherol levels as compared to participants in a “fruit and breakfast cereal” 
pattern, and a “milk and milk products” pattern. Further, in African-Americans 
(n=373), those in a “juice” cluster (characterized by high intakes of fruit juice) had 
higher serum α-tocopherol levels relative to those in a “fast food” cluster 
(characterized by high intakes of fast food, salty snacks, non-diet soft drinks, and 
meat) [45].  
In Northern European populations, the association of vitamin E levels with dietary 
patterns is not well explored.  
 
1.4  Vitamin E and metabolic conditions and gallstone disease 
In the present thesis, circulating vitamin E levels will be related to a broad spectrum 
of cardiometabolic traits. These traits and some prior evidence regarding their 
associations with vitamin E levels are described below. 
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1.4.1  Association of circulating vitamin E levels with the metabolic syndrome 
The metabolic syndrome (MetS) is a clustering of metabolic risk factors and 
conditions and considered present when at least 3 of the 5 following conditions are 
present: Abdominal obesity, hyperglycemia, elevated blood pressure, reduced 
concentration of HDL-cholesterol, and elevated triglyceride concentrations [46]. 
Individuals with the MetS are at high risk for developing type 2 diabetes mellitus and 
cardiovascular diseases [47, 48].  
Some prior studies have related circulating vitamin E levels to the MetS in clinical 
and epidemiological settings, but the results were partially conflicting [49-52]. 
Godala et al. [51] reported lower levels of vitamin E in 182 individuals with the MetS 
compared to 91 healthy adults, whereas Li et al. [52] found no differences in serum 
vitamin E levels between individuals with the MetS (n=221) and healthy adults 
(n=329). Likewise, Beydoun et al. [49] observed no association of vitamin E levels 
with the MetS (n=3008). With respect to individual components of the MetS, vitamin 
E adjusted for lipids was positively related to high triglyceride levels but not to low 
HDL-cholesterol levels in samples from the National Health and Nutrition 
Examination Survey (NHANES; n=4322 and n=8465, respectively) [49, 50].  
 
1.4.2  Association of circulating vitamin E levels with body fat volumes  
Obesity is generally defined by an excessive body fat accumulation and represents 
a major risk factor for a number of chronic diseases, including cardiovascular 
diseases, type 2 diabetes mellitus, and cancer [53].  
Abdominal adipose tissue can be divided in different compartments, including 
subcutaneous (SAT) and visceral adipose tissue (VAT) with SAT representing 
almost 90% of the adipose tissue [54]. Compared to SAT, VAT adipocytes are more 
metabolically active, more insulin-resistant, and produce a higher number of 
inflammatory cells and hormones [54]. Both types of adipose tissues are positively 
related to metabolic risk factors but VAT tends to be more strongly associated with 
greater cardiometabolic risk than SAT [55]. 
Many prior studies used body mass index (BMI) or waist circumference as surrogate 
measures for adiposity and some of these studies explored the associations of BMI 
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or waist circumference with vitamin E levels [56-60]. Two studies related vitamin E 
levels to body fat volumes, as assessed by dual energy X-ray absorptiometry (DXA) 
[59] and bioelectrical impedance analysis (BIA) [58]. So far, there were no studies 
published assessing the association of vitamin E levels with body fat volumes 
derived by magnetic resonance imaging (MRI). 
 
1.4.3  Association of circulating vitamin E levels with liver fat content 
Fatty liver disease (FLD) is defined as an excess accumulation of liver fat and 
comprises a wide spectrum of liver diseases ranging from simple fatty liver disease 
to non-alcoholic steatohepatitis (NASH), which may progress to fibrosis and to 
cirrhosis [61]. FLD has been shown to be associated with metabolic disturbances 
such as dyslipidemia, hypertension, and type 2 diabetes mellitus [62-64]. 
In some prior studies, the association of vitamin E levels with NASH has been 
assessed in rather small samples [65-67]. For example, Machado et al. [65] 
observed higher serum vitamin E levels in patients with NASH (n=43, histologically 
proven) compared to healthy controls (n=33). However, Erhardt et al. [66] observed 
lower vitamin E levels in 50 patients with NASH (biopsy-proven) compared to 40 
healthy controls. Likewise, Bahcecioglu et al. [67] reported lower vitamin E levels in 
patients with biopsy-proven NASH (n=29) than in healthy controls (n=10). 
 
1.4.4  Association of circulating vitamin E levels with gallstone disease 
Gallstone disease refers to the presence of stones in the gallbladder or common 
bile duct system [68]. Gallstones are composed mainly of cholesterol, bilirubin, and 
calcium salts [69]. In most cases, gallstones are clinically asymptomatic (80%), but 
they can lead to complications such as acute cholecystitis or gallstone pancreatitis 
[70]. A few well-established risk factors have been identified, including age, female 
gender, obesity, and dyslipidemia [70-72].  
Associations of vitamin E levels with gallstone disease have been observed in some 
prior reports in rather small studies [73-75]. For example, in a study from 
Worthington et al. [73], lower levels of the α-tocopherol/cholesterol ratio were 
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observed in patients with gallstone disease (n=18) compared to healthy controls 
(n=47). Likewise, Rocchi et al. [74] reported lower levels of the α-
tocopherol/cholesterol ratio in 16 patients with gallstone disease compared to 20 
healthy controls. Besides, Shukla et al. [75] observed lower levels of α-tocopherol 
in individuals with gallstone disease (n=30) compared to healthy controls (n=30).  
 
1.5  Aims  
The aims of this doctoral thesis were: 
1. To assess the distribution of vitamin E levels in a general population sample 
(Chapter 2). 
2. To investigate clinical and biochemical correlates of vitamin E, and its 
associations with a priori and a posteriori derived dietary patterns (Chapter 2).  
3. To study the associations of vitamin E levels with MetS, with MRI-derived body 
fat volumes and with liver fat content in a general population sample (Chapter 3).  
4. To evaluate the association between vitamin E levels and gallstone disease 
(Chapter 4). 
These 4 scientific questions were addressed in 3 separate articles and published in 
peer-reviewed journals.  
For this present thesis, data from the first follow-up examination of the PopGen 
control cohort from Northern Germany (Kiel) were used, as described in detail in 
Chapter 2, 3, and 4.  
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5 General discussion 
The main results of the presented papers were as follows: 
1. Almost 40% of the participants of our sample met the national recommendations 
for the dietary vitamin E intake. Close to 60% of our participants had adequate 
circulating α-tocopherol levels above 30 μmol/L (Chapter 2). 
2. Triglycerides, HDL- and LDL-cholesterol, and vitamin E supplementation were 
statistically significant correlates of vitamin E levels. Both, a priori and a 
posteriori derived dietary patterns were not associated with circulating vitamin E 
levels (Chapter 2).  
3. The α- and γ-tocopherol/cholesterol ratios were positively associated with 
different metabolic traits, including VAT, SAT, the MetS, and two of its 
components, high triglyceride levels and low HDL-cholesterol levels. No 
significant associations were observed when α- and γ-tocopherol/cholesterol 
ratios were studied in relation to LSI or FLD (Chapter 3).  
4. A lower probability of having gallstone disease was observed with increasing α-
tocopherol/cholesterol ratio. An inverse association of the γ-
tocopherol/cholesterol with gallstone disease was observed, even though this 
association did not reach statistical significance (Chapter 4). 
 
5.1 Dietary vitamin E intake and distribution of vitamin E levels 
In our sample from Northern Germany, 38.8% of the participants met the national 
guidelines for dietary vitamin E intake [1]. This proportion was slightly lower than in 
a report from Germany (n=15.371), where 52% of men and 51% of women met the 
respective guidelines [2]. In a study from the US (n=4351), only 4.9% of men and 
4.5% of women met the current recommendation (15 mg/day) for dietary vitamin E 
[3]. It has to be kept in mind that the current dietary intake recommendations of the 
DGE are based on α-tocopherol and do not consider other vitamin E forms [1]. Thus, 
the calculated vitamin E intakes are lower than the actual intakes of dietary vitamin 
E [4]. 
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With respect to circulating vitamin E levels, the observed median of plasma α- (31.54 
μmol/L) and γ-tocopherol (1.35 μmol/L) concentrations in our sample were in 
agreement with prior studies conducted in Germany, reporting, e.g., mean serum 
concentrations of α-tocopherol of 34.4 µmol/L [5] and 30.4 μmol/L [6]. In the present 
sample, circulating levels of α-tocopherol and the α-tocopherol/cholesterol ratio 
(median: 5.53 μmol/mmol) were slightly higher than in the NHANES sample (median 
of α-tocopherol: 26.9 μmol/L, median of α-tocopherol/cholesterol ratio: 4.93 
μmol/mmol) [7]. 
About 60% of individuals in our sample had circulating α-tocopherol levels above 30 
µmol/L. This proportion is slightly higher than in other studies on Europeans (39%) 
and higher than in samples from the US (13%) [8]. There are only few studies on 
the distribution of γ-tocopherol in Europe, but most of them reported similar levels 
as observed in our sample [9, 10]. However, most studies conducted in the US 
reported higher average plasma γ-tocopherol levels as compared to Europeans [10, 
11], because γ-tocopherol is the major form (≈70%) of vitamin E consumed in the 
US [12].  
Regarding vitamin E supplementation, the prevalence of vitamin E supplement 
users in our sample was relatively low (7.5%). The proportion of vitamin E 
supplement users in the German National Nutrition Survey (NVS) II (11.4%) [2] and 
in the National Health Interview Survey from the US is slightly higher (11.4%) [13] 
than in our sample. Data from the NVS II reported a median intake of supplemented 
vitamin E of about 10 mg/day, assessed by diet history interviews [2].  
In our sample, participants provided information about their use of vitamin E 
supplements within the FFQ, which only included a single question related to vitamin 
E supplementation (intake of vitamin E supplements, ‘yes’ or ‘no’). More information 
about vitamin E supplementation, e.g., about the frequency, the amount, and the 
concentration of vitamin E supplements were unfortunately not part of the FFQ and, 
therefore, not available for our analyses. 
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5.2 Lack of association between estimated dietary α-tocopherol 
intake and circulating vitamin E levels 
Of note, we observed no evidence for a correlation between dietary α-tocopherol 
intake and circulating α-tocopherol levels in our sample (Chapter 2). Even though 
this observation is surprising, a review of the literature revealed that several prior 
studies also reported poor or no correlations of dietary vitamin E intake and 
circulating α-tocopherol concentrations [14-16]. Other studies, however, reported 
positive correlations, which were likely due to supplemental intake [17-19]. For 
example, in a study from Stryker et al. [18] (n=330), a poor correlation of plasma 
vitamin E with dietary vitamin E intake (r=0.12) was observed, while a strong 
correlation with dietary vitamin E intake including the use of supplements was 
reported (r=0.51). Likewise, Ascherio et al. [19] observed in a sample of 307 men 
and women a strong positive association between plasma α-tocopherol 
concentrations (r=0.51 in men, r=0.41 in women) and dietary vitamin E intake due 
to supplemental intake. 
Several factors could contribute to the observed lack of correlation between dietary 
vitamin E intake as assessed by FFQ and circulating vitamin E levels. 
First, the FFQ does not capture all foods rich in vitamin E (e.g., olives) and while the 
vitamin E content of oils differs by type (e.g., refined oils have lower vitamin E 
content as compared to unrefined oils) and brand [20, 21], the FFQ is not able to 
differentiate between different oils. Furthermore, vitamin E content in foods is 
influenced by light, temperature, and oxygen availability promoting rancidity in 
vegetable oils. Therefore, the oxidative stability of vitamin E in edible oils is limited 
and vegetable oils might contribute less to vitamin E intake [22]. 
Second, individuals might underreport the intake of vitamin E, because it might be 
difficult to assess the amount of fats and oils added during food preparations [22, 
23].  
Third, circulating vitamin E levels and the FFQ capture very different time intervals. 
The FFQ assesses a more long-term intake (the past 12 months), while α-tocopherol 
appears in plasma within 2-4 hours, peaks in 5-14 hours and disappears from 
plasma with a half-life of 48 hours [24, 25].  
CHAPTER 5  GENERAL DISCUSSION 
72 
 
Fourth, substantial inter-individual differences with respect to the efficiency of 
vitamin E absorption (between 20% and 80%) have been reported [26, 27]. The 
parallel intake of additional food ingredients (e.g., retinoic acid, plant sterols, and 
dietary fiber) can decrease the absorption of vitamin E [27, 28].  
Fifth, in addition to dietary intake, circulating vitamin E concentrations are also 
determined by other factors such as genetic variability, and physiological (gender, 
age) and lifestyle (e.g., smoking, obesity, and alcohol consumption) factors [27-29].  
All these factors might have contributed to the poor correlation between dietary α-
tocopherol intake and plasma α-tocopherol levels observed in this thesis.  
 
5.3 Association of circulating vitamin E levels with metabolic 
traits  
Vitamin E has been found to reduce the risk for several chronic disease conditions 
due to its anti-oxidant and its anti-inflammatory properties [30].  
 
5.3.1 Metabolic syndrome, body fat volumes, and liver fat content 
We observed in our sample from the general population that circulating vitamin E 
levels were positively associated with the prevalence of the MetS and with MRI-
determined body fat volumes (particularly VAT). By contrast, we did not find 
evidence for a statistically significant association of vitamin E levels with MRI-
measures of liver fat content and FLD. 
Previous studies that have examined the association of circulating vitamin E 
concentrations with MetS revealed inconsistent results [31-34], as described in 
detail in the introduction. With respect to adiposity-related traits, our observations 
are in line with several prior studies that displayed a positive association of 
circulating vitamin E levels with adiposity measures (e.g., BMI, waist circumference) 
[35-37]. However, no association of circulating vitamin E levels with body fat 
determined by DXA and BIA was reported [35, 38].  
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Potential mechanisms for the positive associations of vitamin E levels with MetS and 
VAT include the following:  
First, decreased catabolism of α-tocopherol from plasma has been reported in 
individuals with the MetS as compared to healthy adults [34], possibly leading to 
higher plasma α-tocopherol levels in individuals with the MetS as compared to 
individuals without the MetS.  
Second, with respect to α-TTP, several experimental studies suggest that oxidative 
stress could modulate the activity of α-TTP and, thus, potentially influences the 
vitamin E status and leading to higher circulating α-tocopherol levels [39-42].  
Third, regarding the excretion of vitamin E, α-tocopherol can be secreted in bile, but 
it is still unknown if excretion via bile is altered in individuals with the MetS [34]. 
Traber et al. [34] suggest that the hepatic metabolism of α-tocopherol to the α-
tocopherol metabolite α-CEHC may be inhibited in individuals with the MetS. They 
observed that individuals with the MetS excrete lower amounts of urinary α- and γ-
CEHC as compared to individuals without the MetS [34], suggesting that individuals 
with the MetS need more vitamin E, because of increased oxidative stress. Thus, 
individuals with the MetS retain more vitamin E than individuals without the MetS 
[34], possibly leading to higher plasma α-tocopherol levels. 
Fourth, the adipose tissue produces several pro-inflammatory cytokines such as 
tumor necrosis factor-α and IL (interleukin)-6, which promote inflammation and 
oxidative stress [43, 44]. Of note, VAT releases 2 to 3 times more IL-6 than SAT 
[44]. High concentrations of these inflammatory biomarkers could be responsible for 
increased oxidative stress and, thus, leading to higher circulating vitamin E levels. 
In this thesis, stronger associations of γ-tocopherol/cholesterol ratio as compared to 
α-tocopherol/cholesterol ratio with VAT and SAT were observed, which might be 
explained by the unique anti-inflammatory properties of γ-tocopherol [45].  
The lack of association of circulating vitamin E levels with parameters of liver fat in 
our sample is in contrast with some clinical studies, which have reported lower 
vitamin E levels in patients with NASH than in healthy controls [46, 47]. It is 
conceivable that circulating vitamin E levels are primarily altered in individuals with 
an advanced liver disease [48], but not in relatively healthy individuals from the 
general population with modest alterations in liver fat content, as in our sample. With 
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respect to vitamin E as an anti-oxidant, in clinical studies, elevated systemic markers 
of oxidative stress and lipid peroxidation have been found in patients with non-
alcoholic fatty liver disease (NAFLD) and NASH [49-52]. For example, Yesilova et 
al. [49] observed higher levels of oxidative stress markers (malondialdehyde) and 
lower levels of anti-oxidative enzymes such as superoxide dismutase (SOD) and 
catalase (CAT) in patients with NAFLD (n=30) compared to healthy adults (n=30). 
Furthermore, higher levels of oxidized LDLs and thiobarbituric acid reactive 
substances (TBARS) were reported in 21 NASH patients compared to 19 healthy 
controls [50].  
 
5.3.2 Gallstone disease 
In our sample, we found an inverse association of α-tocopherol with gallstone 
disease. Thus, higher levels of α-tocopherol were associated with a lower probability 
of having gallstone disease. As detailed in the introduction, this is in line with prior 
studies [53-55].  
Some studies reported higher levels of oxidative stress markers in patients with 
gallbladder disease as compared to healthy controls [56, 57]. Specifically, higher 
levels of conjugated dienes, lipid hydroperoxides, and TBARS and lower levels of 
anti-oxidative enzymes including CAT and SOD as well as glutathione related 
enzymes have been found in the gallbladder mucosa of 30 patients with 
cholecystectomy due to gallstone disease compared to 15 individuals without 
gallstones [56]. Furthermore, higher levels of lipid peroxides (LPO) and nitric oxides 
(NO) were reported in 107 patients with chronic cholecystitis containing gallstones 
as compared to 100 healthy controls [57]. Moreover, it has been shown that levels 
of oxidative stress markers (LPO and NO) decrease after gallbladder surgery 
compared to the preoperative state [57]. Thus, individuals with higher circulating 
vitamin E levels could be better protected from oxidative stress and, therefore, 
develop less gallstones.  
Further, previous studies observed impaired vitamin E absorption in patients with 
cholestatic diseases [58, 59]. Due to cholestatic diseases inadequate amounts of 
bile salts, essential for absorption of lipid-soluble vitamins [60], are delivered to the 
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intestinal lumen and, consequently, result in a lipid-soluble vitamin malabsorption 
[61].  
 
5.4 Future research 
Based on the results from the present thesis, there are many research questions 
related to vitamin E that could be addressed in the future. The role of vitamin E as 
an anti-oxidant and its relation to the MetS, body fat volumes, liver fat content, and 
gallstone disease is not fully understood and has been addressed in cross-sectional 
analyses in the present thesis. Further investigations in a prospective setting within 
the general population, relating vitamin E to the incidence of the above mentioned 
metabolic traits are warranted.  
As indicated above, the FFQ does not capture all vitamin E rich foods and is not 
able to differentiate between different oil types and brands [20, 21]. Therefore, an 
update of the vitamin E content in foods, food groups, or meals is of major interest. 
A representative data basis for all substances (e.g, nutrients, environmental 
contaminants, food additives) in foods will be established in the first total diet study, 
called the Federal Institute for risk assessement (BfR, Bundesinstitut für 
Risikobewertung) Meal study. In the BfR Meal Study, foods are being analyzed in 
ready-to-eat condition (foods are prepared as consumed). The BfR Meal Study 
provides a newly generated FFQ database reflecting typically eating habits in 
Germany. In this way, the BfR Meal Study makes it possible to get new detailed 
data about the content of vitamin E in foods, food groups, and meals [62]. Thus, it 
would be very interesting to re-evaluate the findings in this thesis.  
Another important area of research in the context of vitamin E would be genetic 
analyses related to different vitamin E biomarkers. Two prior genome-wide 
association studies (GWAS) for vitamin E levels have been reported so far [63, 64]. 
The first GWAS, conducted in a moderately-sized Italian sample (n=1190), reported 
a single nucleotide polymorphism (SNP) near the apolipoprotein A5 gene to be 
associated with α-tocopherol levels [63]. While a p-value of 7.8 x 10-10 was reached 
in a meta-analysis including the discovery and the replication samples, this 
association was substantially attenuated upon adjustment for triglyceride levels 
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(p=0.002). US-based researchers conducted a GWAS for α- and γ-tocopherol [64] 
in a much larger sample (n=5006) and reported 3 new SNPs that reached genome-
wide significance in their association with α-tocopherol, explaining together 1.7% of 
the inter-individual variation in α-tocopherol. Furthermore, a previously reported 
SNP, associated with α-tocopherol, could be replicated. However, no genetic variant 
convincingly associated with circulating γ-tocopherol levels could be identified. 
Further genetic analyses, also including rare and low-frequency variants, could 
provide a better understanding of the genetic underpinning of inter-individual 
variation in vitamin E levels.  
 
5.5 Conclusion 
The present thesis explored in detail the distribution of circulating plasma vitamin E 
levels (α- and γ-tocopherol) in a general population sample of moderate size, 
assessed clinical and nutritional correlates of vitamin E; and related circulating 
vitamin E biomarkers (α- and γ-tocopherol) to cardiometabolic traits, including the 
MetS, body fat volumes, liver fat content, and gallstone disease. 
We observed that nearly 40% of the participants in our sample met the 
recommendations for dietary α-tocopherol intake from foods (issued by the DGE). 
An even higher proportion (57.6%) had adequate α-tocopherol levels in plasma 
above 30 μmol/L.  
Because of the increasing interest in possible health effects of vitamin E and the 
anti-oxidative functions that vitamin E participates in, prospective studies between 
α- and γ-tocopherol levels and metabolic conditions, liver fat content, and gallstone 
disease in general populations studies are warranted. 
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6 Summary 
Vitamin E is a lipid-soluble vitamin encompassing different vitamin E forms (α-, β-, 
γ-, δ-tocopherols, and tocotrienols) with important anti-oxidative functions. There is 
limited knowledge regarding the distribution of plasma vitamin E concentrations in 
the general Northern German population, the relation of vitamin E to dietary 
patterns, and its association with cardiometabolic traits. Therefore, in this thesis, the 
distribution of both α- and γ-tocopherol levels was assessed in a sample from the 
general population; and biochemical and dietary correlates of vitamin E were 
explored. We observed, that nearly 60% of the Northern German population had 
adequate plasma α-tocopherol levels (>30 µmol/L), and that lipid traits and the 
intake of vitamin E supplementation were statistically significantly associated with 
circulating vitamin E levels. However, neither a priori nor a posteriori derived dietary 
patterns displayed an association with circulating α- and γ-tocopherol levels. 
Furthermore, we explored associations of plasma vitamin E levels with the following 
cardiometabolic traits: The metabolic syndrome (MetS), visceral (VAT) and 
subcutaneous (SAT) adipose tissue, liver signal intensity (LSI), fatty liver disease 
(FLD), and gallstone disease. The α-tocopherol/cholesterol ratio was positively 
associated with MetS (Odds Ratio (OR): 1.83; 95% Confidence Interval (CI): 1.21-
2.76 for 3rd vs. 1st tertile) and VAT (β scaled by interquartile range (IQR): 0.036; 
95% CI: 0.0003; 0.071); and the γ-tocopherol/cholesterol ratio was positively 
associated with MetS (OR: 1.87; 95% CI: 1.23-2.84 for 3rd vs. 1st tertile), VAT (β 
scaled by IQR: 0.066; 95% CI: 0.027; 0.104), and SAT (β scaled by IQR: 0.048; 
95% CI: 0.010; 0.087). However, no association of the α-tocopherol/cholesterol ratio 
or of the γ-tocopherol/cholesterol ratio with LSI and FLD was observed. Lower odds 
of having gallstone disease were observed in the top (compared to the bottom) 
tertile of the plasma α-tocopherol/cholesterol ratio (OR: 0.31; 95% CI: 0.13-0.76). A 
similar trend was observed for the γ-tocopherol/cholesterol ratio, but the association 
did not reach statistical significance. All analyses were conducted using data from 
the first follow-up examination (2010-2012) of the PopGen control cohort, a 
population-based sample from Northern Germany. Populations based, prospective 
studies are warranted to confirm our results and to further explore the potential 
impact of the reported findings on other nutritional and health outcomes.
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7 Zusammenfassung 
Vitamin E ist ein fettlösliches Vitamin und umfasst verschiedene Vitamin E-Formen 
(α-, β-, γ-, δ-Tocopherole und Tocotrienole) mit anti-oxidativen Funktionen. Bislang 
ist wenig über die Verteilung von Vitamin E-Plasmaspiegeln in der 
Allgemeinbevölkerung in Norddeutschland bekannt. Weiterhin ist unklar, welche 
Ernährungsmuster und Einflussfaktoren mit Vitamin E-Plasmaspiegeln assoziiert 
sind. Im Rahmen der vorliegenden Arbeit wurden der Vitamin E (α- und γ-
Tocopherol)-Status in einer Stichprobe der Allgemeinbevölkerung bestimmt und 
biochemische und ernährungsbezogene Einflussfaktoren identifiziert, die mit 
Vitamin E-Plasmaspiegeln korrelieren. Ca. 60% unserer Stichprobe wiesen 
adäquate Vitamin E-Plasmaspiegel (>30 μmol/L) auf. Allerdings zeigten a priori und 
a posteriori Ernährungsmuster keinen statistisch signifikanten Zusammenhang mit 
Vitamin E-Plasmaspiegeln. Weiterhin wurde die Assoziation von Vitamin E-
Plasmaspiegeln mit dem Metabolischen Syndrom (MetS), dem viszeralen (VAT) 
und subkutanen (SAT) Körperfett, der Lebersignalintensität (LSI), der 
Fettlebererkrankung (FLD) und mit Gallensteinen untersucht. Das α-
Tocopherol/Cholesterol Verhältnis war mit dem MetS (Chancenverhältnis (OR): 
1,83; 95% Konfidenzintervall (CI): 1,21-2,76; 3.Tertil vs. 1.Tertil) und mit VAT (β 
skaliert durch den IQR (Interquartilsabstand): 0,036; 95% CI: 0,003; 0,017) positiv 
assoziiert. Das γ-Tocopherol/Choesterol Verhältnis war positiv mit dem MetS 
(OR:1,87; 95% CI: 1,23-2,84; 3.Tertil vs. 1.Tertil), VAT (β skaliert durch den IQR: 
0,066; 95% CI: 0,027; 0,104) und SAT (β skaliert durch den IQR: 0,048; 95% CI: 
0,010; 0,087) assoziiert. Allerdings fand sich kein Zusammenhang zwischen dem 
Vitamin E/Cholesterol Verhältnis und der LSI und der FLD. Studienteilnehmer/innen 
mit höheren Werten für das α-Tocopherol/Cholesterol Verhältnis (3. Tertil) wiesen 
im Vergleich zu Personen mit niedrigeren Werten (1. Tertil) eine geringere 
Wahrscheinlichkeit auf, Gallensteine zu haben (OR: 0,31; 95% CI: 0,13-0,76). Ein 
ähnlicher Trend konnte auch für das γ-Tocopherol/Choesterol Verhältnis 
beobachtet werden, jedoch war dieser Zusammenhang nicht statistisch signifikant. 
Für die vorliegenden Analysen wurden Daten der 1. Nachuntersuchung (2010-
2012) der PopGen-Kontrollkohorte verwendet, die eine populationsbasierte 
Stichprobe aus Norddeutschland darstellt. Populationsbasierte, prospektive Studien 
CHAPTER 7  ZUSAMMENFASSUNG 
84 
 
sind nötig, um die vorliegenden Ergebnisse zu bestätigen und deren Relevanz auf 
andere ernährungswissenschaftliche und gesundheitliche Aspekte zu untersuchen. 
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